FSD Pharma's market cap is currently ―. The company's EPS TTM is $-0.466; its P/E ratio is -1.00; FSD Pharma is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	$ -7.11M	$ -7.95M	$ -5.44M
EBITDA	-	-	$ -5.97M	$ -6.82M	$ -4.34M
Net Income Common Stockholders	-	-	$ -7.13M	$ -4.42M	$ -5.91M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.51M	$ 16.98M	$ 23.78M	$ 31.62M	$ 28.57M
Total Assets	$ 17.47M	$ 38.41M	$ 43.58M	$ 51.17M	$ 55.71M
Total Debt	$ 339.20K	$ 516.42K	$ 556.97K	$ 508.39K	$ 552.50K
Net Debt	$ -3.17M	$ -16.46M	$ -23.22M	$ -31.11M	$ -28.02M
Total Liabilities	$ 4.57M	$ 7.87M	$ 7.44M	$ 8.59M	$ 8.95M
Stockholders Equity	$ 13.24M	$ -115.66M	$ 36.14M	$ 42.58M	$ 46.76M
Cash Flow	-
Free Cash Flow	-	-	$ -7.61M	$ -9.40M	$ -5.36M
Operating Cash Flow	-	-	$ -7.52M	$ -9.40M	$ -5.09M
Investing Cash Flow	-	-	$ -96.92K	$ 12.72M	$ -106.59K
Financing Cash Flow	-	-	$ -257.77K	$ -275.25K	$ -1.49M

Currency in USD

FSD Pharma Earnings and Revenue History

Income Statement >

FSD Pharma Debt to Assets

Balance Sheet >

FSD Pharma Cash Flow

Cash Flow >

FSD Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing